Variant report
Variant | nsv1061528 |
---|---|
Chromosome Location | chr19:22081275-22104599 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZNF257-1 | chr19:22100052-22101719 | XLOC_013010 |
2 | lnc-ZNF257-1 | chr19:22085706-22085729 | XLOC_013010 |
3 | lnc-ZNF257-4 | chr19:22099324-22099462 | NONHSAT063754 |
4 | lnc-ZNF257-4 | chr19:22097817-22098563 | NONHSAT063754 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554498953 | chr19:22082811-22082812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs143270483 | chr19:22082818-22082819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs116630713 | chr19:22082883-22082884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565174649 | chr19:22082902-22082903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541457260 | chr19:22082913-22082914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139120010 | chr19:22082922-22082923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563056350 | chr19:22082954-22082955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73552281 | chr19:22082967-22082968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546815406 | chr19:22082983-22082984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559748918 | chr19:22082991-22082992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs147455525 | chr19:22083065-22083066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182042030 | chr19:22083091-22083092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567261432 | chr19:22083101-22083102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528228831 | chr19:22083108-22083109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114158381 | chr19:22083115-22083116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187652894 | chr19:22083130-22083131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538468681 | chr19:22083149-22083150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557074510 | chr19:22083170-22083171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10406494 | chr19:22083222-22083223 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs189844236 | chr19:22083287-22083288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554586636 | chr19:22083368-22083369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs555066493 | chr19:22083378-22083379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572887737 | chr19:22083430-22083431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140621870 | chr19:22083436-22083437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370471547 | chr19:22083451-22083452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558649206 | chr19:22083461-22083462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577233273 | chr19:22083486-22083487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs391264 | chr19:22083490-22083491 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs180692611 | chr19:22083526-22083527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185352471 | chr19:22083531-22083532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542524186 | chr19:22083535-22083536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536549573 | chr19:22083545-22083546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560895288 | chr19:22083560-22083561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571888823 | chr19:22083653-22083654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs78325576 | chr19:22083666-22083667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs71178790 | chr19:22083668-22083669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs56906217 | chr19:22083669-22083670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs391190 | chr19:22083682-22083683 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs114642507 | chr19:22083730-22083731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564836900 | chr19:22083738-22083739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73930134 | chr19:22083756-22083757 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs391527 | chr19:22083788-22083789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190111924 | chr19:22083819-22083820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536190566 | chr19:22083887-22083888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141298790 | chr19:22083931-22083932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs528336802 | chr19:22083944-22083945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546199350 | chr19:22083968-22083969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs73930135 | chr19:22083970-22083971 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs138999787 | chr19:22089607-22089608 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
50 | rs149873766 | chr19:22089621-22089622 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chordoma | 18071362 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Cervical cancer | 21063398 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Lung cancer | 18438408 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Colorectal cancer | 20459617 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Cancer | 20164920 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:22082800-22084000 | Enhancers | Placenta | Placenta |
2 | chr19:22089600-22090800 | ZNF genes & repeats | Placenta | Placenta |
3 | chr19:22091200-22091800 | Active TSS | Fetal Heart | heart |
4 | chr19:22093000-22093600 | ZNF genes & repeats | HUES48 Cell Line | embryonic stem cell |
5 | chr19:22100600-22102400 | ZNF genes & repeats | Adipose Nuclei | Adipose |
6 | chr19:22101800-22102600 | ZNF genes & repeats | Duodenum Smooth Muscle | Duodenum |